Wedbush Predicts Weaker Earnings for Apellis Pharmaceuticals
Apellis Pharmaceuticals, Inc. (NASDAQ:APLS – Free Report) – Investment analysts at Wedbush decreased their Q1 2025 earnings per share estimates for Apellis Pharmaceuticals in a research report issued on Wednesday, April 16th. Wedbush analyst L. Chico now expects that the company will post earnings per share of ($0.46) for the quarter, down from their prior […]
Apellis Pharmaceuticals, Inc. (NASDAQ:APLS – Free Report) – Investment analysts at Wedbush decreased their Q1 2025 earnings per share estimates for Apellis Pharmaceuticals in a research report issued on Wednesday, April 16th. Wedbush analyst L. Chico now expects that the company will post earnings per share of ($0.46) for the quarter, down from their prior […]
